• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Back to Search Results
Model Number CDK-1413
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 04/21/2018
Event Type  Injury  
Manufacturer Narrative
Case-(b)(4).The device was not returned for evaluation but a device history review was obtained for lot number 73597.There is nothing in the device history record that would indicate that the devices were released with any non-conformances that would contribute to the complaint.
 
Event Description
It was reported on (b)(6) 2018, that a (b)(6) - year- old female patient had an off-pump convergent study procedure.On post-op day two, patient complained of shortness of breath on exertion.Patient treated with lasix and echocardiogram showed no pericardial effusion.Patient was discharged.On post-op day 20, (b)(6) 2018, patient visited for a post procedure transthoracic echocardiography (tte) and presented with complaints of shortness of breath, fatigue and cough.Tte result showed moderate pericardial effusion.Patient sent to the emergency room and was admitted with pericardial effusion concerning for tamponade.On (b)(6) 2018, the subject underwent sub-xiphoid pericardial window procedure.A large, bloody effusion was drained, and a right-angled chest tube was placed in the pericardial space.The subject was transferred out of the operating room in stable condition and later discharged.This event has previously been reported to the agency under ide study # (b)(4).This event has been adjudicated as a procedural issue as part of the ide study # (b)(4).Although this event has not been attributed to the device, atricure is reporting this event under part 806.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Type of Device
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Manufacturer (Section D)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer (Section G)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer Contact
john ehlert
7555 innovation way
mason, OH 45040
5137554563
MDR Report Key7790696
MDR Text Key117420790
Report Number3011706110-2018-00201
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Model NumberCDK-1413
Device Catalogue NumberCDK-1413
Device Lot Number73597
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/21/2018
Initial Date FDA Received08/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/27/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age57 YR
Patient Weight90
-
-